期刊文献+

铝-锂合金应变率负敏感效应及动态韧性现象 被引量:4

THE INVERTED STRAIN-RATE SENSITIVITY OF Al-Li ALLOYES AND THEIR PROPERTIES OF DYNAMIC DUCTILITY
下载PDF
导出
摘要 本文从实验上揭示了铝-锂合金奇特的应变率负敏感效应和动态韧性特性,并应用作者所建议的无屈服型粘塑性本构模型对其力学行为从理论上进行了描述和讨论。 In this research.the specimens of 270AI-Li alloy subjected to three different thermal-heated conditions are tested by different static and dynamic experimental method. Through comparision of the static and dynamic experimental results, it is shown that Al-Li alloyes have the unusual effects of inverted strain-rate sensitivity and properties of dynamic ductility. Furthermore, for the purpose of practical applications, the above mechanical behaviours of the Al-Li alloy are described and discussed theoretically by use of the no-yield visco-plastic model which was proposed by the authors. The theoretical calculated curves show consistency with the experimental very well.
出处 《爆炸与冲击》 EI CAS CSCD 北大核心 1989年第3期193-198,共6页 Explosion and Shock Waves
关键词 铝锂合金 应变率 负敏感效应 韧性 inverted strain-rate sensitivity, dynamic ductility, constitutive model, vis-co-plasticity.
  • 相关文献

同被引文献23

  • 1CS Pichot, SM Hartig, L Xia, et al. Dasatinib synergizes with doxorubi- cin to block growth, migration, and invasion of breast cancer cells [J]. British Journal of Cancer, 2009, 101 (1) : 38.
  • 2Shor AC, Keschman EA, Lee FY, et al. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma ceils dependent on SRC kinase for survival [ J] . Cancer Res, 2007, 67 (6): 2800.
  • 3Song L, Morris M, Bagui T, et al. Dasatinib ( BMS - 354825 ) selec- tively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival [J]. Cancer Res, 2006, 66 (11): 5542.
  • 4Serrels A, Macpherson IR, Evans TR, et al. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib[J]. Mol Cancer Ther, 2006, 5 (12) : 3014.
  • 5Nam S, Kim D, Chcng JQ, et al. Action of the Src family kinase inhibi- tor, dasatinib (BMS-354825), on human prostate cancer cells [J) . Cancer Res, 2005, 65 (20): 9185.
  • 6Jobnson FM, Saigal B, Talpaz M, et al. Dasatinib ( BMS - 354825 ) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non - small cell lung cancer cells [J] . Clin Cancer Res, 2005, 11 ( 19pt1) : 6924.
  • 7Chang, Jorgensen C, Pawson T, et al. Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer [J] . British Journal of Cancer, 2008, 99 (7) : 1074.
  • 8Guanglei Zhuang, Dana M, Brantley - Sieders, et al. Elevation of re- ceptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy [J]. Cancer Research, 2010, 70 (1): 299.
  • 9Traxler P. Tyrosine kinases as targets in cancer therapy - successes and failures [J] . Expert Opinion Ther Targets, 2003, 7 (2) : 215.
  • 10Normanno N, De Luca A, Bianco C, et al, Epidermal growth factor re- ceptor (EGFR) signaling in cancer [ J ]. Gene,2006,366 ( 1 ) : 2.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部